Speakers

Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 4th Viral Vector Process Development & Manufacturing Summit

Paul Freeman

Head of Upstream Process Science & Vector Core Scientist
Affinia Therapeutics

Matt Edwards

Vice President - Process Science
Affinia Therapeutics

Von Wiltman

Associate Director - Technical Operations
Apertura Gene Therapy

Christopher Davis

Director, Nonclinical and Translational Research
Apertura Gene Therapy

Aditya Dandekar

Associate Director
Cabaletta Bio

Scott Jeffers

CTO
GenSight Biologics

Amol Thote

Team Lead & Head Of Process Development
Gilead Sciences

Michael Dibiasio White

Independent Consultant
Independent Expert

Kok Seong Lim

Independent Cell & Gene Therapy CMC Expert
Independent Expert

Valerie Ng

Associate Director- Regulatory Affairs CMC
Kite Pharma Inc

David Mcnally

Executive Director & Head of Viral Vector Technology
Mass Biologics

Rachel Beyer

Head - cGMP Viral Vector Laboratory
National Cancer Institute

Chirag Khatiwala

Vice President - Process Development & Manufacturing
Obsidian Therapeutics

Sushmita “Mimi” Roy

Vice President - Technical Development, Chemistry, Manufacturing & Controls Operations
Rocket Pharmaceuticals Ltd.

Wei-Chiang Chen

Associate Director
Sanofi

Brett Howard

Senior Director, US Regulatory Policy
U.S. Pharmacopeia

Ishtiaq Khaliq

Lead Gene Therapy Molecular Biology Sciences
UCB

Ying Cai

Executive Director - Manufacturing Sciences & Technology
Ultragenyx Pharmaceutical Inc.

Event Photo - 4th Viral Vector Process Development & Manufacturing Summit

Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

View Presentations & Speakers

Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Explore Sponsorship Options

Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.